The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Close X
Other videos you might like

Recent Videos


Glucagon-Containing Dual and Triple Agonists For Obesity and MASH

Scott Harris,

Watch time: 8m 36s


ECO 24: Long-Term Weight Loss in the SELECT trial

Donna H Ryan,

Watch time: 11m 42s


ECO 24: Increasing GLP1-RA Efficacy by Targeting Non-coding RNA

Riccardo Panella,

Watch time: 4m 50s


ECO 24: The STEP 10 Trial

Barbara McGowan,

Watch time: 8m 28s


ECO 24: EASL-EASD-EASO Practice Guidelines for MAFLD

Sven M Francque,

Watch time: 10m 28s


HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie,

Watch time: 15m 26s